FDA Approves DOXEPIN HYDROCHLORIDE — Ajanta Pharma USA Inc.
Ajanta Pharma USA Inc. received FDA approval on September 13, 2019, for the oral generic of doxepin hydrochloride. The approval is expected to impact the market by increasing competition against the brand formulation and potentially lowering prices for this therapeutic agent.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed